Loading...
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis
BACKGROUND: Although infliximab treatment is an option for patients with ulcerative colitis (UC), not all patients do respond to therapy, and cellular mechanisms leading to therapy response are incompletely known. OBJECTIVE: The objective of this article is to determine early effects of infliximab t...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4040739/ https://ncbi.nlm.nih.gov/pubmed/24917999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640613502962 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|